Labiotech.eu

News and Trends 27 Feb 2016

What happened this week? European Biotechs on NASDAQ, Onxeo’s CEO Interview, NGS Battle

Monday: Meet the CEO of a Confident Orphan Oncology Biotech from France & Denmark Tuesday: 7 Trendy European Biotechs Listed on the NASDAQ in 2016 Wednesday: Your Microbiome even Impacts how Tall you are! Thursday: NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious) Friday: Faces of Bioart: Depicting the Psychology of Petri […]

February 27, 2016 - 1 minutemin - By Philip Hemme

News and Trends 26 Feb 2016

A New Super-Antibody against Ebola has been Isolated

Humabs BioMed (Switzerland), in collaboration with institutional partners has succeeded in isolating new antibodies against the Ebola virus and turned them into a potential therapy against it. Humabs discovers monoclonal antibodies by doing blood analysis of survivors to given infectious diseases. For example, if one wants the cure for the flu, it looks into people […]

February 26, 2016 - 3 minutesmins - By Denise Neves Gameiro

suzanne ankler bioart zoosemiotics MRI butterfly vanitas petri remote sensing 3D print rainbow loom

News and Trends 26 Feb 2016

Faces of Bioart: Depicting the Psychology of Petri Dishes and Chromosomes with Suzanne Anker

Suzanne Anker is a must-know in the BioArt community, with expositions around the world and directing her own BioArt lab in New York. She explores artefacts that have become icons of Biology – such as chromosomes, MRI scans and Petri dishes. Around the same time the Human Genome Project was initiated, Anker exhibited Zoosemiotics (1993). […]

February 26, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 26 Feb 2016

Biotech of the week: Kallistem, producing Functional In vitro Spermatozoids in France

This week, we leave Lisbon, Portugal and head up to Lyon, the so-called gastronomical capital of France. Besides bird watching, a beautiful cathedral and a multi-purpose Roman amphitheatre, and of course delicious food, Lyon is where Kallistem, our Biotech of the Week, is located. City: Lyon, France Founded: 2012 Employees: 7 (as of 02/2016) Financial Data: N/A CEO: […]

February 26, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 25 Feb 2016

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

NGS-Giant Illumina (US) is suing Oxford Nanopore (UK), the Unicorn ready to disrupt gene sequencing. What’s the story? Illumina currently has the monopoly on NGS equipment, and Illumina’s machines make a common (and bulky) fixture in labs all over the world. In the future, many hospitals will move into data-driven medicine and NGS plays an important […]

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

nestle health sciences pronutria investment amino acids food

News and Trends 25 Feb 2016

Boston Food Biotech Gets €38M from Nestlé

Pronutria (US) is a start-up out of Flagship Ventures developing nutritional therapies which has now gotten a huge equity investment from Nestlé Health Science (Switzerland). Pronutria is a cool Biotech start-up taking an innovative approach to treat diseases caused by amino acid imbalance, such as muscle loss, and neurological and liver complications. Besides being essential for protein synthesis, […]

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 25 Feb 2016

High Quality Grade plasmids for a better gene therapy

Quality of RNA and viral vectors used in clinical trials is subject to strict regulation. Plasmids that are needed for production of these complex molecules are also on authorities’ radar. German-based biotech PlasmidFactory, delivers the right solution with its High Quality Grade plasmids. For decades, artificially constructed plasmids have been used as vectors in genetic […]

February 25, 2016 - 4 minutesmins - By Joachim Eeckhout

News and Trends 24 Feb 2016

German Biotech wins FDA Approval for New Liver Cancer Trial

4SC, in Germany, has the FDA’s green light to conduct efficacy trials in the US with a candidate drug against hepatocellular carcinoma. Munich-based 4SC’s lead candidate, resminostat, is a small-molecule being tested in several trials for some of the deadliest cancers. These include liver – which is also known as hepatocellular carcinoma (HCC). Resminostat is an inhibitor of histone […]

February 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiome lyon czech mouse igf1 growth research

News and Trends 24 Feb 2016

Your Microbiome even Impacts how Tall you are!

Research at the University of Lyon (France) and Czech Academy of Sciences have found a previously unknown link between the microbiome and Human growth, as well as a potential therapeutic application for Lactobacillus plantarum. The microbiome is a hot field for research and Health Biotechs alike, and Europe is home to some of the leaders in […]

February 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

aspergillosis aspergillus mathias eu pet mri

News and Trends 23 Feb 2016

This new Antibody-based Imaging Technology could help fight Deadly Fungal Infections

It is estimated that up to 200,000 people globally die from fungal lung infections (Aspergillosis). Now, the EU-funded Fp7 MATHIAS project has developed an imaging technique to help doctors fight this huge killer of patients with weakened immune systems. The new test involves attaching radioactively labelled antibodies to the infecting structures formed by the fungus Aspergillus fumigatus. These fungal spores […]

February 23, 2016 - 3 minutesmins - By Dani Bancroft

gilead hiv aids grant retroviral truvada

News and Trends 23 Feb 2016

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

The US Giant Gilead is opening a new program of Grants to fund the next generation of HIV research for 3-years. Targets are academic institutions and non-profit organization. HIV remains a global health challenge, with around 37 million people infected in the world. The rate of new infections fell in the last decades, but it is […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

desktop genetics gene ngs illumina epigenetics

News and Trends 23 Feb 2016

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Desktop Genetics, a small bioinformatics start-up out of London, has won a substantial grant to understand why some cancer cells just won’t quit. To do this, it relies on CRISPR, their expertise with genetic data, and research from Imperial College London. Desktop Genetics has already proven that it can move some money, with a €1.87 […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What happened this week? European Biotechs on NASDAQ, Onxeo’s CEO Interview, NGS Battle

A New Super-Antibody against Ebola has been Isolated

Faces of Bioart: Depicting the Psychology of Petri Dishes and Chromosomes with Suzanne Anker

Biotech of the week: Kallistem, producing Functional In vitro Spermatozoids in France

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

Boston Food Biotech Gets €38M from Nestlé

High Quality Grade plasmids for a better gene therapy

German Biotech wins FDA Approval for New Liver Cancer Trial

Your Microbiome even Impacts how Tall you are!

This new Antibody-based Imaging Technology could help fight Deadly Fungal Infections

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!